Search results for "Highlights"
IV iron regimens compared for serum phosphate effects in patients with IBD
Ferric carboxymaltose and ferric derisomaltose worked well to resolve anemia from inflammatory bowel disease (IBD), but the former was associated with low serum phosphate levels, according to an industry-funded trial.
https://gastroenterology.acponline.org/archives/2022/09/23/2.htm
23 Sep 2022
Review examines drugs, lifestyle treatments for NAFLD
The umbrella review included 27 meta-analyses of randomized controlled trials examining the effectiveness of pharmacological interventions and lifestyle modifications, including diet and exercise, for patients with nonalcoholic fatty liver disease (NAFLD).
https://gastroenterology.acponline.org/archives/2022/05/27/2.htm
27 May 2022
High consumption of ultra-processed foods associated with CRC in men
Among women, only consumption of ready-to-eat or -heat mixed dishes was linked to increased risk of colorectal cancer (CRC), according to a new analysis of the Health Professionals Follow-up Study and Nurses' Health Studies.
https://gastroenterology.acponline.org/archives/2022/09/23/3.htm
23 Sep 2022
Fatty liver disease may not affect mortality risk in elderly patients
In a Dutch cohort study of patients ages 65 years and older, no association was found between hepatic steatosis and death in the overall population or in clinically relevant subgroups.
https://gastroenterology.acponline.org/archives/2022/07/22/3.htm
22 Jul 2022
Electronic alert about lactulose linked to lower readmissions in patients with cirrhosis
The alert, which encouraged clinicians to prescribe rifaximin for patients with cirrhosis and hepatic encephalopathy who were on lactulose, increased uptake of rifaximin in such patients.
https://gastroenterology.acponline.org/archives/2022/01/28/3.htm
28 Jan 2022
DPP-4 inhibitors associated with risk of cholecystitis, meta-analysis finds
Patients with type 2 diabetes who were randomized to receive dipeptidyl peptidase-4 (DPP-4) inhibitors had higher rates of gallbladder disease than those who got placebo or nonincretin drugs, but no difference in risk of cholelithiasis or biliary diseases.
https://gastroenterology.acponline.org/archives/2022/07/22/6.htm
22 Jul 2022
HCV treatment effective, but underutilized, studies show
One study found that re-infection rates are low after successful hepatitis C virus (HCV) treatment in people who inject drugs, while another found that use of direct-acting antivirals in patients diagnosed with HCV is low, regardless of insurance status.
https://gastroenterology.acponline.org/archives/2022/08/26/3.htm
26 Aug 2022
New guideline offers recommendations on managing antithrombotic drugs during GI bleeds, endoscopies
The American College of Gastroenterology and the Canadian Association of Gastroenterology offered suggestions for management of patients on warfarin, direct oral anticoagulants, and antiplatelet agents.
https://gastroenterology.acponline.org/archives/2022/03/25/1.htm
25 Mar 2022
HCV medications decreased liver disease among those using injection drugs
A Baltimore-based study found that half of participants with chronic hepatitis C virus (HCV) and a history of injection drug use at baseline were free of the virus by 2019, with associated reductions in their risk of cirrhosis and mortality.
https://gastroenterology.acponline.org/archives/2022/07/22/2.htm
22 Jul 2022
Colonoscopy common, riskier in those with life expectancy of less than 10 years
A study of patients undergoing screening colonoscopy after age 75 years found that relatively few cancers were found and treated and that the risk of adverse events requiring hospitalization was high and rose with age.
https://gastroenterology.acponline.org/archives/2023/04/21/1.htm
21 Apr 2023